AU2002249232A1 - Use of $g(g)-gt inhibitors for the treatment of degenerative diseases - Google Patents

Use of $g(g)-gt inhibitors for the treatment of degenerative diseases

Info

Publication number
AU2002249232A1
AU2002249232A1 AU2002249232A AU2002249232A AU2002249232A1 AU 2002249232 A1 AU2002249232 A1 AU 2002249232A1 AU 2002249232 A AU2002249232 A AU 2002249232A AU 2002249232 A AU2002249232 A AU 2002249232A AU 2002249232 A1 AU2002249232 A1 AU 2002249232A1
Authority
AU
Australia
Prior art keywords
inhibitors
treatment
degenerative diseases
degenerative
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249232A
Inventor
Helmut Sies
Gunter Wagner
Hans Weiher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GTX Pharmaceuticals GmbH
Original Assignee
GTX Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GTX Pharmaceuticals GmbH filed Critical GTX Pharmaceuticals GmbH
Publication of AU2002249232A1 publication Critical patent/AU2002249232A1/en
Abandoned legal-status Critical Current

Links

AU2002249232A 2001-02-20 2002-02-20 Use of $g(g)-gt inhibitors for the treatment of degenerative diseases Abandoned AU2002249232A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01104063.1 2001-02-20

Publications (1)

Publication Number Publication Date
AU2002249232A1 true AU2002249232A1 (en) 2002-09-04

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
EP1511730B8 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
AU2002339157A1 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2002338807A1 (en) Use of c-kit inhibitors for the treatment of myeloma
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2001285747A1 (en) Method for the treatment of tobacco
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
AU2002303145A1 (en) Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2002333510A1 (en) Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
AU2003297363A1 (en) Use of cathepsin k inhibitors for the treatment of glaucoma
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
GB0201025D0 (en) The treatment of degenerative diseases
AU2002249232A1 (en) Use of $g(g)-gt inhibitors for the treatment of degenerative diseases
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
GB0100092D0 (en) Treatment of degenerative diseases
AU2003262140A1 (en) Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
AU2002342715A1 (en) Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
AU2003289889A1 (en) Methods for the treatment of alzheimers disease and compositions therefore
AU2002343085A1 (en) Tnf-alpha inhibitors for the treatment of hepatic diseases
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors